Search

Displaying results 6821 - 6830 of 6949 in total
  1. Drug

    Lestaurtinib

    go.drugbank.com/drugs/DB06469
    Investigational

  2. Drug

    Cinalukast

    go.drugbank.com/drugs/DB00587
    Experimental

    Used in the treatment of asthma, cinalukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. … Cinalukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.

  3. Drug

    Sarizotan

    go.drugbank.com/drugs/DB06454
    Investigational

  4. Drug

    Dihydromorphine

    go.drugbank.com/drugs/DB01565
    ExperimentalIllicit

    A semisynthetic analgesic used in the study of narcotic receptors. It has abuse potential. [PubChem]

  5. Drug

    MKC-1

    go.drugbank.com/drugs/DB05608
    Investigational

  6. Drug

    IPH 1101

    go.drugbank.com/drugs/DB05754
    Experimental

    IPH 1101 is a chemically-synthesized structural analog of non-conventional bacterial phosphoantigens which specifically activate the Vγ9Vδ2 T cell subset. IPH 1101 is the most advanced drug candidate of the γδ T cell platform

  7. Drug

    Diethylnorspermine

    go.drugbank.com/drugs/DB06445
    Investigational

  8. Drug

    Tezampanel

    go.drugbank.com/drugs/DB06354
    Investigational

    Tezampanel is an AMPA receptor antagonist.

  9. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

    Categories: Purinergic P2 Receptor Antagonists
  10. Drug

    XL999

    go.drugbank.com/drugs/DB05014
    Investigational

    XL999 is a new chemical entity that inhibits a spectrum of receptor tyrosine kinases (RTKs) with growth promoting and angiogenic properties, including FGFR 1/3, PDGFRα/β, VEGFR2/KDR, KIT, and FLT3.